FDA Updates Highlighting the Latest Cancer Treatments : Oncology Times
An abstract is unavailable.
An abstract is unavailable.
The Fortel PSA Screening Test has been approved by the United Arab Emirates MOHAP for the rapid detection of early signs of prostate cancer.
Panelists discuss how risk stratification tools and patient-specific factors guide treatment selection and timing of interventions for patients with newly diagnosed intermediate 2–risk myelofibrosis, with…
on has been widely studied and implemented in the thoracic and lumbar spine. However less literature exists regarding the use of computer-assisted navigation for posterior…
Preliminary data show that AVA6000 led to robust and clinically meaningful tumor shrinkage in patients with salivary gland cancer.
Explore JAAOS peer-reviewed articles covering the expanse of orthopaedic medicine and representing over 39,000 members of the AAOS. Subscribe today!
Bevacizumab’s survival benefits in CRC patients persist for about 2 years after starting treatment.
First-line IMM-1-104 plus chemotherapy produced responses and disease control in patients with pancreatic cancer.
Zhang et al. investigate immune cell dynamics in TNBC patients treated with paclitaxel, nab-paclitaxel, and combinations with atezolizumab. They identify distinct underlying cellular mechanisms, revealing that…
Although gallbladder and bile duct cancers are different diseases, they’re often discussed together. They each have a connection to bile, a fluid that helps with…
Get the inside scoop from Drs Lou, Patel, and Beg on the top takeaways to come out of the 2025 Gastrointestinal Cancers Symposium.